Status:
COMPLETED
Disease Modifying Genes in Severe Asthma
Lead Sponsor:
NYU Langone Health
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.
Eligibility Criteria
Inclusion
- Ages 18 and above
Exclusion
- Greater than 10 pack year tobacco history
- Lung diseases other than asthma
Key Trial Info
Start Date :
April 8 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 23 2019
Estimated Enrollment :
941 Patients enrolled
Trial Details
Trial ID
NCT00212537
Start Date
April 8 2002
End Date
July 23 2019
Last Update
August 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU School of Medicine
New York, New York, United States, 10016